Tirzepatide Prescribing at TOWER HOUSE SURGERY
Drugs used in diabetes | Endocrine System
Items (12m)
749
Total Quantity
775
NHS Cost
£71.3K
vs National Avg
+285.6%
TOWER HOUSE SURGERY prescribed 749 items of Tirzepatide over the last 12 months at a cost of £71,339 to the NHS. This is 285.6% above the national average prescribing rate. Tirzepatide is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jun 2026
25
Jun 2026
30
Jun 2026
47
Jun 2026
49
Jun 2026
58
Jun 2026
66
Jun 2026
78
Jun 2026
69
Jun 2026
76
Jun 2026
81
Jun 2026
82
Jun 2026
88
Prescribing Details
| Total Items | 749 |
|---|---|
| Total Quantity | 775 |
| Total NHS Cost | £71,339 |
| Presentations | 6 different forms |
| vs National Average | +285.6% |
Tirzepatide Prescribing Comparison
| This practice | 749 items |
|---|---|
| National average per practice | 194 items |
| Difference | +285.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.